Jump Financial’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-52,456
Closed -$314K 2340
2026
Q1
$314K Buy
+52,456
New +$395K ﹤0.01% 1458
2025
Q2
Sell
-24,702
Closed -$368K 2059
2025
Q1
$368K Buy
24,702
+10,402
+73% +$160K ﹤0.01% 1209
2024
Q4
$213K Sell
14,300
-20,037
-58% -$327K ﹤0.01% 1461
2024
Q3
$657K Buy
+34,337
New +$712K 0.01% 996
2023
Q1
Sell
-14,545
Closed -$406K 1927
2022
Q4
$406K Sell
14,545
-4,658
-24% -$119K 0.02% 872
2022
Q3
$449K Buy
19,203
+5,701
+42% +$172K 0.02% 935
2022
Q2
$456K Buy
+13,502
New +$473K 0.02% 897

Other funds holding OGN

Jump Financial's OGN Position: Q2 2026 in Review

Jump Financial sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 52,456 shares — an estimated $314K sold.

Jump Financial first reported a position in OGN in Q2 2022 and held it in 7 quarters. The position peaked at $657K in Q3 2024. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Jump Financial reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
  • Jump Financial sold 52,456 Organon & Co shares in Q2 2026, an estimated $314K.
  • Jump Financial first reported a position in Organon & Co in Q2 2022 and held it in 7 quarters.
  • Jump Financial's Organon & Co position peaked at $657K in Q3 2024.
  • 627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.